Mucin genes in gallstone disease

Clinica Chimica Acta

Volumn 413, Issue 19-20, 2012, Pages 1466-1471

  Chuang, Shih Chang ^a,b,c   Hsi, Edward ^b,c   Lee, King Teh ^a,c  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Gallstone; MUC gene; Mucin gene

Indexed keywords

MESSENGER RNA; MUCIN; MUCIN 1; MUCIN 12; MUCIN 17; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 5B; MUCIN 6; MUCIN LIKE PROTOCADHERIN; UNCLASSIFIED DRUG;

CHOLELITHIASIS; GALLSTONE FORMATION; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MUCIN GENE; MUCUS SECRETION; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

BILE; BILE ACIDS AND SALTS; CHOLESTEROL; GALLBLADDER; GALLSTONES; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUCINS; MULTIGENE FAMILY; POLYMORPHISM, GENETIC; PROTEIN ISOFORMS;

ANIMALIA;

EID: 84862627783     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2012.06.015     Document Type: Review

References (95)

1. Acalovschi M. Cholesterol gallstones: from epidemiology to prevention. Postgrad Med J 2001, 77:221-229.
2. Loria P., Dilengite M.A., Bozzoli M., et al. Prevalence rates of gallstone disease in Italy. The Chianciano population study. Eur J Epidemiol 1994, 10:143-150.
3. Glambek I., Kvaale G., Arnesjo B., Soreide O. Prevalence of gallstones in a Norwegian population. Scand J Gastroenterol 1987, 22:1089-1094.
4. Prathnadi P., Miki M., Suprasert S. Incidence of cholelithiasis in the northern part of Thailand. J Med Assoc Thai 1992, 75:462-470.
5. Chen C.Y., Lu C.L., Huang Y.S., et al. Age is one of the risk factors in developing gallstone disease in Taiwan. Age Ageing 1998, 27:437-441.
6. Lammert F., Sauerbruch T. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat Clin Pract Gastroenterol 2005, 2:423-433.
7. Wang H.H., Portincasa P., Wang D.Q.H. Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci 2008, 13:401-423.
8. Mittal B., Mittal R.D. Genetics of gallstone disease. J Postgrad Med 2002, 48:149-152.
9. Katsika D., Grjibovski A., Einarsson C., et al. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005, 41:1138-1143.
10. Kern F., Everson G.T., DeMark B., et al. Biliary lipids, bile acids, and gallbladder function in the human female. Effects of pregnancy and the ovulatory cycle. J Clin Invest 1981, 68:1229-1242.
11. Dowling R.H. Review: pathogenesis of gallstones. Aliment Pharmacol Ther 2000, 14(Suppl. 2):39-47.
12. Grünhage F., Lammert F. Pathogenesis of gallstones: a genetic perspective. Best Pract Res Clin Gastroenterol 2006, 20:997-1015.
13. Kosters A., Jirsa M., Groen A.K. Genetic background of cholesterol gallstone disease. Biochim Biophys Acta, Mol Basis Dis 2003, 1637:1-19.
14. Wittenburg H. Hereditary liver disease: gallstones. Best Pract Res Clin Gastroenterol 2010, 24:747-756.
15. Raffel L.J. The epidemiology and genetic basis of common diseases. Pediatr Ann 1997, 26:525-534.
16. Puppala S., Dodd G.D., Fowler S., et al. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am J Hum Genet 2006, 78:377-392.
17. Iida M., Okayama Y., Goto K., et al. Gallstone classification and analysis of their constituents. Nihon Rinsho 1993, 51:1718-1724.
18. Small D.M. Cholesterol nucleation and growth in gallstone formation. N Engl J Med 1980, 302:1305-1307.
19. Holan K.R., Holzbach R.T., Hermann R.E., et al. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979, 77:611-617.
20. Levy P.F., Smith B.F., LaMont J.T. Human gallbladder mucin accelerates nucleation of cholesterol in artificial bile. Gastroenterology 1984, 87:270-275.
21. Portincasa P., Moschetta A., Palasciano G. Cholesterol gallstone disease. Lancet 2006, 368:230-239.
22. Mendez-Sanchez N., Cardenas-Vazquez R., Ponciano-Rodriguez G., et al. Pathophysiology of cholesterol gallstone disease. Arch Med Res 1996, 27:433-441.
23. Lee K.T., Liu T.S. Mucin gene expression in gallbladder epithelium. J Formos Med Assoc 2002, 101:762-768.
24. Chuang S.C., Juo S.H., Hsi E., et al. Multiple mucin genes polymorphisms are associated with gallstone disease in Chinese men. Clin Chim Acta 2011, 412:599-603.
25. Chuang S.C., Hsi E., Wang S.N., et al. Polymorphism at the mucin-like protocadherin gene influences susceptibility to gallstone disease. Clin Chim Acta 2011, 412:2089-2093.
26. Allen A., Flemstrom G., Garner A., et al. Gastroduodenal mucosal protection. Physiol Rev 1993, 73:823-857.
27. Moniaux N., Escande F., Porchet N., et al. Structural organization and classification of the human mucin genes. Front Biosci 2001, 6:D1192-D1206.
28. Slomiany B.L., Zdebska E., Slomiany A. Structural characterization of neutral oligosaccharides of human H+Leb+ gastric mucin. J Biol Chem 1984, 259:2863-2869.
29. Sasaki M., Ikeda H., Nakanuma Y. Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem 2007, 42:61-110.
30. Keicho N., Hijikata M. Genetic predisposition to diffuse panbronchiolitis. Respirology 2011, 16:581-588.
31. Pigny P., Guyonnet-Duperat V., Hill A.S., et al. Human mucin genes assigned to 11p15.5: identification and organization of a cluster of genes. Genomics 1996, 38:340-352.
32. Paris M.J., Williams B.R. Characterization of a 500-kb contig spanning the region between c-Ha-Ras and MUC2 on chromosome 11p15.5. Genomics 2000, 69:196-202.
33. Sheen P.C., Lee K.T., Liu Y.E. Mucin content in gallbladders with brown pigment stones or combination stones with a brown periphery. Digestion 1998, 59:660-664.
34. Lee K.T., Liu T.S. Mucin gene expression in gallbladder epithelium with black pigment stone ascertained by in situ hybridization. Kaohsiung J Med Sci 2001, 17:517-523.
35. Buisine M.P., Devisme L., Degand P., et al. Developmental mucin gene expression in the gastroduodenal tract and accessory digestive glands. II. Duodenum and liver, gallbladder, and pancreas. J Histochem Cytochem 2000, 48:1667-1676.
36. Vilkin A., Nudelman I., Morgenstern S., et al. Gallbladder inflammation is associated with increase in mucin expression and pigmented stone formation. Dig Dis Sci 2007, 52:1613-1620.
37. Afdhal N.H., Offner G.D., Murray F.E., et al. Isolation and characterization of peptides from the protein core of bovine gallbladder mucin. Gastroenterology 1990, 98:1633-1641.
38. van Klinken B.J., Dekker J., van Gool S.A., et al. MUC5B is the prominent mucin in human gallbladder and is also expressed in a subset of colonic goblet cells. Am J Physiol 1998, 274:G871-G878.
39. Ho S.B., Shekels L.L., Toribara N.W., et al. Altered mucin core peptide expression in acute and chronic cholecystitis. Dig Dis Sci 2000, 45:1061-1071.
40. Womack N.A., Zeppa R., Irvin G.L. The anatomy of gallstones. Ann Surg 1963, 157:670-686.
41. Hulten O. Formation of gallstones. II. Acta Chir Scand 1968, 134:557-561.
42. Womack N.A. The development of gallstones. Surg Gynecol Obstet 1971, 133:937-945.
43. Englert E., Harman C.G., Freston J.W., et al. Studies on the pathogenesis of diet-induced dog gallstones. Am J Dig Dis 1977, 22:305-314.
44. Freston J.W., Bouchier I.A., Newman J. Biliary mucous substances in dihydrocholesterol-induced cholelithiasis. Gastroenterology 1969, 57:670-678.
45. Lee S.P., LaMont J.T., Carey M.C. Role of gallbladder mucus hypersecretion in the evolution of cholesterol gallstones. J Clin Invest 1981, 67:1712-1723.
46. Pai-Ching Sheen J.M., King-Teh L., Yueh-Er L. Mucin content in gallbladderswith brown pigment stones or combination stones with a brown periphery. Digestion 1998, 59:660-664.
47. Smith B.F., LaMont J.T. Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones. J Clin Invest 1985, 76:439-445.
48. Bar Dayan Y., Vilkin A., Niv Y. Gallbladder mucin plays a role in gallstone formation. Eur J Intern Med 2004, 15:411-414.
49. Rege R.V., Prystowsky J.B. Inflammation and a thickened mucus layer in mice with cholesterol gallstones. J Surg Res 1998, 74:81-85.
50. Baig S.J., Biswas S., Das S., et al. Histopathological changes in gallbladder mucosa in cholelithiasis: correlation with chemical composition of gallstones. Trop Gastroenterol 2002, 23:25-27.
51. Zen Y., Harada K., Sasaki M., et al. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am J Pathol 2002, 161:1475-1484.
52. Thai P., Loukoianov A., Wachi S., et al. Regulation of airway mucin gene expression. Annu Rev Physiol 2008, 70:405-429.
53. Maurer K.J., Carey M.C., Fox J.G. Roles of infection, inflammation, and the immune system in cholesterol gallstone formation. Gastroenterology 2009, 136:425-440.
54. Thornton D.J., Sheehan J.K. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thorac Soc 2004, 1:54-61.
55. Jüngst C., Sreejayan N., Eder M.I., et al. Lipid peroxidation and mucin secretagogue activity in bile of gallstone patients. Eur J Clin Invest 2007, 37:731-736.
56. Finzi L., Barbu V., Burgel P.R., et al. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptor pathway in the human gallbladder. Am J Pathol 2006, 169:2031-2041.
57. Song K.S., Lee W.J., Chung K.C., et al. Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases-MSK1-CREB activation in human airway epithelial cells. J Biol Chem 2003, 278:23243-23250.
58. Gray T., Nettesheim P., Loftin C., et al. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol Pharmacol 2004, 66:337-346.
59. Maurer K.J., Rao V.P., Ge Z., et al. T-cell function is critical for murine cholesterol gallstone formation. Gastroenterology 2007, 133:1304-1315.
60. Levine S.J., Larivee P., Logun C., et al. Tumor necrosis factor-alpha induces mucin hypersecretion and MUC-2 gene expression by human airway epithelial cells. Am J Respir Cell Mol Biol 1995, 12:196-204.
61. Kim Y.D., Jeon J.Y., Woo H.J., et al. Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, and PI3K in human airway epithelial cells. J Korean Med Sci 2002, 17:765-771.
62. Bai C.H., Song S.Y., Kim Y.D. The inhibitory effect of the leukotriene receptor antagonist on leukotriene D4-induced MUC2/5AC gene expression and mucin secretion in human airway epithelial cells. Auris Nasus Larynx 2007, 34:203-206.
63. LaMont J.T., Smith B.F., Moore J.R. Role of gallbladder mucin in pathophysiology of gallstones. Hepatology 1984, 4:51S-56S.
64. Afdhal N.H., Niu N., Nunes D.P., et al. Mucin-vesicle interactions in model bile: evidence for vesicle aggregation and fusion before cholesterol crystal formation. Hepatology 1995, 22:856-865.
65. Sasaki M., Nakanuma Y., Kim Y.S. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 1998, 27:54-61.
66. Ganesh I.M., Subramani D., Halagowder D. Mucin glycoarray in gastric and gallbladder epithelia. J Carcinogenesis 2007, 6:10.
67. Lee K.T., Liu T.S. Altered mucin gene expression in stone-containing intrahepatic bile ducts and cholangiocarcinomas. Dig Dis Sci 2001, 46:2166-2172.
68. Bouchier I.A., Cooperband S.R., El-Kodsi B.M. Mucous substances and viscosity of normal and pathological human bile. Gastroenterology 1965, 49:343-353.
69. Lee S.P., Lim T.H., Scott A.J. Carbohydrate moieties of glycoproteins in human hepatic and gall-bladder bile, gall-bladder mucosa and gall stones. Clin Sci (Lond) 1979, 56:533-538.
70. Lee T.J., Smith B.F. Bovine gallbladder mucin promotes cholesterol crystal nucleation from cholesterol-transporting vesicles in supersaturated model bile. J Lipid Res 1989, 30:491-498.
71. LaMont J.T., Ventola A.S., Trotman B.W., et al. Mucin glycoprotein content of human pigment gallstones. Hepatology 1983, 3:377-382.
72. Kim H.J., Kim S.H., Chae G.B., et al. Increased expression of mucin 5AC mRNA and decreased expression of epidermal growth-factor receptor mRNA in gallstone patients. Tohoku J Exp Med 2008, 214:139-144.
73. Albores-Saavedra J., Nadji M., Henson D.E., et al. Intestinal metaplasia of the gallbladder: a morphologic and immunocytochemical study. Hum Pathol 1986, 17:614-620.
74. Yamagiwa H., Tomiyama H. Intestinal metaplasia-dysplasia-carcinoma sequence of the gallbladder. Acta Pathol Jpn 1986, 36:989-997.
75. Carlei F., Lygidakis N.J., Barsotti P., et al. Mucin-producing cells and endocrine cells of gallbladder epithelium in patients with uncomplicated cholelithiasis. Hepatogastroenterology 1991, 38:149-153.
76. Kim H.J., Kim J.S., Kim K.O., et al. [Expression of MUC3, MUC5AC, MUC6 and epidermal growth factor receptor in gallbladder epithelium according to gallstone composition]. Korean J Gastroenterol 2003, 42:330-336.
77. Vilkin A., Geller A., Levi Z., et al. Mucin gene expression in bile of patients with and without gallstone disease, collected by endoscopic retrograde cholangiography. World J Gastroenterol 2009, 15:2367-2371.
78. LaMont J.T., Turner B.S., DiBenedetto D., et al. Arachidonic acid stimulates mucin secretion in prairie dog gallbladder. Am J Physiol 1983, 245:G92-G98.
79. Lee S.P., Carey M.C., LaMont J.T. Aspirin prevention of cholesterol gallstone formation in prairie dogs. Science 1981, 211:1429-1431.
80. Rhodes M., Allen A., Dowling R.H., et al. Inhibition of human gall bladder mucus synthesis in patients undergoing cholecystectomy. Gut 1992, 33:1113-1117.
81. Broomfield P.H., Chopra R., Sheinbaum R.C., et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988, 319:1567-1572.
82. Rhodes M., Allen A., Lennard T.W. Mucus glycoprotein biosynthesis in the human gall bladder: inhibition by aspirin. Gut 1992, 33:1109-1112.
83. Jüngst C., Sreejayan N., Zündt B., et al. Ursodeoxycholic acid reduces lipid peroxidation and mucin secretagogue activity in gallbladder bile of patients with cholesterol gallstones. Eur J Clin Invest 2008, 38:634-639.
84. Buch S., Schafmayer C., Volzke H., et al. A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease. Nat Genet 2007, 39:995-999.
85. Srivastava A., Pandey S.N., Dixit M., et al. Cholecystokinin receptor A gene polymorphism in gallstone disease and gallbladder cancer. J Gastroenterol Hepatol 2008, 23:970-975.
86. Nakamoto K., Wang S., Jenison R.D., et al. Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene. BMC Genet 2006, 7:29.
87. Kuo K.K., Shin S.J., Chen Z.C., et al. Significant association of ABCG5 604Q and ABCG8 D19H polymorphisms with gallstone disease. Br J Surg 2008, 95:1005-1011.
88. Klass D.M., Lauer N., Hay B., et al. Arg64 variant of the beta3-adrenergic receptor is associated with gallstone formation. Am J Gastroenterol 2007, 102:2482-2487.
89. Szoka P.R., Paigen K. Genetic regulation of mup production in recombinant inbred mice. Genetics 1979, 93:173-181.
90. Gendler S.J., Spicer A.P., Gendler S.J., et al. Epithelial mucin genes. Annu Rev Physiol 1995, 57:607-634.
91. Verma M., Davidson E.A. Mucin genes: structure, expression and regulation. Glycoconj J 1994, 11:172-179.
92. Wang H.H., Afdhal N.H., Gendler S.J., et al. Evidence that gallbladder epithelial mucin enhances cholesterol cholelithogenesis in MUC1 transgenic mice. Gastroenterology 2006, 131:210-222.
93. Wang H.H., Afdhal N.H., Gendler S.J., et al. Targeted disruption of the murine mucin gene 1 decreases susceptibility to cholesterol gallstone formation. J Lipid Res 2004, 45:438-447.
94. Bouchier I.A., Cooperband S.R. The characteristics of "white bile". Gastroenterology 1965, 49:354-359.
95. Hofmann A.F., Mosbach E.H. Identification of allodeoxycholic acid as the major component of gallstones induced in the rabbit by 5-alpha-cholestan-3-beta-Ol. J Biol Chem 1964, 239:2813-2821.